CRISPR Could Cause Cancer? Here Are 3 Reasons Investors Shouldn't Panic
By Keith Speights | June 13, 2018 |

Newly identified potential issues with CRISPR-Cas9 gene editing aren't as worrisome as you might think.

3 Stocks To Supplement Your Social Security Income
By Keith Speights | June 12, 2018 |
This Tech Giant Is About To Acquire The Status Of Dividend Aristocrat
By Genia Turanova | June 12, 2018 |

This tech company is quietly transforming into an innovator once again, delivering growing income that isn't showing any signs of stopping.

The Cheapest Drug Stocks To Buy Right Now
By Sean Williams | June 11, 2018 |

All three of these bargains have forward P/E ratios of less than eight.

Value Stocks Are Set To Make A Serious Comeback
By Genia Turanova | June 11, 2018 |

They may not be leading the market right now, but if history is any guide, then value stocks are poised to outperform. Here's why...

3 Facts You Didn't Know About The Fast-Food Business
By Demitrios Kalogeropoulos | June 08, 2018 |

A few surprising aspects about the $1.2 trillion market for food on the go.

I Found An Emerging Blue-Chip Stock (But You Won't Believe Where)
By Andy Obermueller | June 08, 2018 |

There's no limit to where and how far this $2 billion company can go -- it's a $100 billion industry leading blue-chip in the making.

Better Buy: Veeva Systems Inc. Vs. athenahealth, Inc.
By Keith Speights | June 07, 2018 |

Which cloud-based healthcare technology stock wins in a head-to-head matchup?

2 Cheap Dividend Stocks You Can Buy Right Now
By Keith Speights | June 06, 2018 |

These two drug stocks have a lot to offer income investors and value investors.

Why 'The List' Could Be Full Of Triple-Digit Winners
By Brad Briggs | June 06, 2018 |

Want Netflix or Amazon-type gains? This report is your best shot.